Boedtkjer D M B, Kim S, Jensen A B, Matchkov V M, Andersson K E
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Skejby, Denmark.
Br J Pharmacol. 2015 Aug;172(16):4158-72. doi: 10.1111/bph.13201. Epub 2015 Jul 8.
T16A(inh)-A01, CaCC(inh)-A01 and MONNA are identified as selective inhibitors of the TMEM16A calcium-activated chloride channel (CaCC). The aim of this study was to examine the chloride-specificity of these compounds on isolated resistance arteries in the presence and absence (±) of extracellular chloride.
Isolated resistance arteries were maintained in a myograph and tension recorded, in some instances combined with microelectrode impalement for membrane potential measurements or intracellular calcium monitoring using fura-2. Voltage-dependent calcium currents (VDCC) were measured in A7r5 cells with voltage-clamp electrophysiology using barium as a charge carrier.
Rodent arteries preconstricted with noradrenaline or U46619 were concentration-dependently relaxed by T16A(inh) -A01 (0.1-10 μM): IC50 and maximum relaxation were equivalent in ±chloride (30 min aspartate substitution) and the T16A(inh) -A01-induced vasorelaxation ±chloride were accompanied by membrane hyperpolarization and lowering of intracellular calcium. However, agonist concentration-response curves ±chloride, with 10 μM T16A(inh) -A01 present, achieved similar maximum constrictions although agonist-sensitivity decreased. Contractions induced by elevated extracellular potassium were concentration-dependently relaxed by T16A(inh)-A01 ±chloride. Moreover, T16A(inh) -A01 inhibited VDCCs in A7r5 cells in a concentration-dependent manner. CaCC(inh) -A01 and MONNA (0.1-10 μM) induced vasorelaxation ±chloride and both compounds lowered maximum contractility. MONNA, 10 μM, induced substantial membrane hyperpolarization under resting conditions.
T16A(inh) -A01, CaCC(inh) -A01 and MONNA concentration-dependently relax rodent resistance arteries, but an equivalent vasorelaxation occurs when the transmembrane chloride gradient is abolished with an impermeant anion. These compounds therefore display poor selectivity for TMEM16A and inhibition of CaCC in vascular tissue in the concentration range that inhibits the isolated conductance.
T16A(inh)-A01、CaCC(inh)-A01和MONNA被鉴定为跨膜蛋白16A(TMEM16A)钙激活氯离子通道(CaCC)的选择性抑制剂。本研究的目的是在细胞外氯离子存在和不存在(±)的情况下,研究这些化合物对分离的阻力动脉的氯离子特异性。
将分离的阻力动脉置于肌张力测定仪中并记录张力,在某些情况下结合微电极刺入以测量膜电位或使用fura-2进行细胞内钙监测。使用钡作为载流子,通过电压钳电生理学在A7r5细胞中测量电压依赖性钙电流(VDCC)。
用去甲肾上腺素或U46619预收缩的啮齿动物动脉被T16A(inh)-A01(0.1-10μM)浓度依赖性舒张:在±氯离子(30分钟天冬氨酸替代)条件下,IC50和最大舒张程度相当,并且T16A(inh)-A01诱导的±氯离子血管舒张伴随着膜超极化和细胞内钙降低。然而,在存在10μM T16A(inh)-A01的情况下,±氯离子的激动剂浓度-反应曲线达到了相似的最大收缩程度,尽管激动剂敏感性降低。细胞外钾升高诱导的收缩被T16A(inh)-A01±氯离子浓度依赖性舒张。此外,T16A(inh)-A01以浓度依赖性方式抑制A7r5细胞中的VDCC。CaCC(inh)-A01和MONNA(0.1-10μM)诱导±氯离子血管舒张,并且两种化合物均降低最大收缩力。10μM的MONNA在静息条件下诱导显著的膜超极化。
T16A(inh)-A01、CaCC(inh)-A01和MONNA浓度依赖性舒张啮齿动物阻力动脉,但当用非渗透性阴离子消除跨膜氯离子梯度时,会出现同等程度的血管舒张。因此,这些化合物对TMEM16A的选择性较差,并且在抑制分离电导的浓度范围内抑制血管组织中的CaCC。